110(top 1%)
papers
2.9K(top 1%)
citations
23(top 1%)
h-index
53(top 1%)
g-index
114
all documents
3.1K
doc citations
883
citing journals

Top Articles

#TitleJournalYearCitations
1Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx RenalCell2018609
2Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast CancerJAMA Oncology2019557
3HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaJournal of Clinical Oncology2018350
4Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung CancerJournal of Thoracic Oncology2012147
5Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for AtezolizumabApplied Immunohistochemistry and Molecular Morphology2019144
6High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma199694
7Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodiesLaboratory Investigation201784
8Aurora-A over-expression in high-grade PIN lesions and prostate cancerProstate200571
9PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancerBreast Journal201865
10Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring studyBreast Cancer Research and Treatment201459
11Effect of Delayed Formalin Fixation on Estrogen and Progesterone Receptors in Breast CancerAmerican Journal of Clinical Pathology201051
12Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphomaBlood201249
13Novel dual-color immunohistochemical methods for detecting ERG–PTEN and ERG–SPINK1 status in prostate carcinomaModern Pathology201347
14A Sensitive ALK Immunohistochemistry Companion Diagnostic Test Identifies Patients Eligible for Treatment with CrizotinibJournal of Thoracic Oncology201746
15Evaluating HPV‐negative CIN2+ in the ATHENA trialInternational Journal of Cancer201643
16BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaHuman Pathology201434
17Metallographic in situ hybridizationHuman Pathology200732
18Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistryInternational Journal of Cancer199531
19Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA).Journal of Clinical Oncology201730
20Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell LymphomaAmerican Journal of Clinical Pathology201329
21Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell LymphomaFrontiers in Immunology201328
22Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon CancerClinical Cancer Research201626
23Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancerBreast Cancer Research and Treatment201726
24Characterization of Natural Product Chemopreventive Agents200526
25Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trialInternational Journal of Cancer202225
26The Utility of BRAF V600E Mutation-Specific Antibody VE1 for the Diagnosis of Hairy Cell LeukemiaAmerican Journal of Clinical Pathology201523
27The CD117 Immunohistochemistry Tissue Microarray Survey for Quality Assurance and Interlaboratory Comparison: A College of American Pathologists Cell Markers Committee StudyArchives of Pathology and Laboratory Medicine200623
28Epidermal growth factor receptor mutation‐specific immunohistochemical antibodies in lung adenocarcinomaHistopathology201422
29Development of a PD-L1 companion diagnostic assay for treatment with MEDI4736 in NSCLC and SCCHN patients.Journal of Clinical Oncology201522
30Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast CancerApplied Immunohistochemistry and Molecular Morphology202121
31ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisJournal of Pathology: Clinical Research201618
32Automated Brightfield Dual-Color In Situ Hybridization for Detection of Mouse Double Minute 2 Gene Amplification in SarcomasApplied Immunohistochemistry and Molecular Morphology201117
33The business value and cost–effectiveness of genomic medicinePersonalized Medicine201217
34ERG Overexpression and PTEN Status Predict Capsular Penetration in Prostate CarcinomaProstate201317
35Identification of HER2 Immunohistochemistry-Negative, FISH-Amplified Breast Cancers and Their Response to Anti-HER2 Neoadjuvant ChemotherapyAmerican Journal of Clinical Pathology201916
36Thymidylate Synthase Protein Expression by IHC and Gene Copy Number by SISH Correlate and Show Great Variability in Non–Small Cell Lung CancerJournal of Thoracic Oncology201215
37Automated Multiplexing Quantum Dots in Situ Hybridization Assay for Simultaneous Detection of ERG and PTEN Gene Status in Prostate CancerJournal of Molecular Diagnostics201315
38HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast CancerAmerican Journal of Clinical Pathology201715
39Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788Clinical Cancer Research201214
40Delta-like Protein 3 Prevalence in Small Cell Lung Cancer and DLL3 (SP347) Assay CharacteristicsArchives of Pathology and Laboratory Medicine201912
41The combined positive impact of Lean methodology and Ventana Symphony autostainer on histology lab workflowBMC Clinical Pathology201011
42Expression of Estrogen Receptor-α and Survival in Advanced-stage Non-small Cell Lung CancerAnticancer Research201811
43Time Gated Luminescence Imaging of Immunolabeled Human TissuesAnalytical Chemistry201710
44Declines Noted in Cognitive Processes and Association With Achievement Among Children With LeukemiaOncology Nursing Forum20179
45Interpathologist Diagnostic Agreement for Non–Small Cell Lung Carcinomas Using Current and Recent ClassificationsArchives of Pathology and Laboratory Medicine20189
46Olaparib plus paclitaxel sensitivity in biomarker subgroups of gastric cancerAnnals of Oncology20189
47Intratumoral CD3+ and CD8+ T-Cell Densities in Patients With DNA Mismatch Repair–Deficient Metastatic Colorectal Cancer Receiving Programmed Cell Death-1 BlockadeJCO Precision Oncology20199
48Final analysis of stage 1 data from a randomized phase II study of PEGPH20 plus nab-Paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients (pts), utilizing Ventana companion diagnostic assay.Journal of Clinical Oncology20169
49BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor PrognosisClinical Lymphoma, Myeloma and Leukemia20218
50Abstract B001: Development of a PD-L1 companion diagnostic IHC assay (SP142) for atezolizumab20168